Rakovina Therapeutics Inc (TSE:RKV) has released an update.
Rakovina Therapeutics Inc. has successfully raised $1.7 million, surpassing its $1.5 million target for a private placement, with plans to increase the financing to $2 million, pending regulatory approval. The funds will boost research efforts in their AI drug-discovery endeavors and collaborations aimed at developing new cancer treatments. Additionally, the company’s annual general meeting saw the re-election of its board members and the re-appointment of its auditor.
For further insights into TSE:RKV stock, check out TipRanks’ Stock Analysis page.
